Evidence map›Paper›PMID 36960961›Full record

ReviewAdvances in respiratory medicine2023

The Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease.

Mandeep Singh Rahi, Bright Thilagar, Swetha Balaji, Sivaguha Yadunath Prabhakaran, Mayuri Mudgal, Suganiya Rajoo, Prashanth Reddy Yella, Palak Satija, Alsu Zagorulko, Kulothungan Gunasekaran

Open access · goldFull text readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advances in respiratory medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 4 pooled it
25.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 4 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Anxiety, depression and acromegaly: a systematic review.Journal of endocrinological investigation · 2025
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Mind over lungs: the impact of coping strategies on pulmonary rehabilitation outcomes.European journal of physical and rehabilitation medicine · 2026
    Observational
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Mandeep Singh RahiDepartment of Pulmonary and Critical Care Medicine, Yale New Haven Health, Lawrence + Memorial Hospital, New London, CT 06320, USA.ORCID 0000-0002-4445-5758
Bright ThilagarDepartment of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Swetha BalajiDivision of Endocrinology and Metabolism, Department of Medicine, University of Illinois, Chicago, IL 60607, USA.
Sivaguha Yadunath PrabhakaranDepartment of Internal Medicine, Kasturba Medical College, Mangalore 575001, India.ORCID 0000-0002-3196-1811
Mayuri MudgalDepartment of Medicine, Camden Clark Medical Center, School of Medicine, West Virginia University, Parkersburg, WV 26101, USA.ORCID 0000-0002-6409-3870
Suganiya RajooDepartment of Hematology and Oncology, WakeMed, Raleigh Campus, Raleigh, NC 27610, USA.
Prashanth Reddy YellaDepartment of Internal Medicine, Yuma Regional Medical Center, 2400 S Avenue A, Yuma, AZ 85364, USA.ORCID 0000-0002-7495-1314
Palak SatijaDepartment of Internal Medicine, Yuma Regional Medical Center, 2400 S Avenue A, Yuma, AZ 85364, USA.
Alsu ZagorulkoDepartment of Psychiatry, Illinois Center for Neurological and Behavioral Medicine, Des Plaines, IL 60016, USA.
Kulothungan GunasekaranDepartment of Pulmonary Diseases and Critical Care, Yuma Regional Medical Center, Yuma, AZ 85364, USA.ORCID 0000-0002-2872-1630
Regional Medical Center · USKasturba Medical College, Mangalore · INMayo Clinic · USUniversity of Illinois Chicago · USWakeMed · USWest Virginia University · USYale New Haven Hospital · USYuma Oncology Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with COPD (chronic obstructive pulmonary disease) are at a higher risk of comorbid conditions such as anxiety and/or depression, which in turn increase their symptom burden and rehospitalizations compared to the general population. It is important to investigate the pathophysiology and clinical implications of mental health on patients with COPD. This review article finds that COPD patients with anxiety and/or depression have a higher rehospitalization incidence. It reviews the current screening and diagnosis methods available. There are pharmacological and non-pharmacologic interventions available for treatment of COPD patients with depression based on severity. COPD patients with mild depression benefit from pulmonary rehabilitation and cognitive behavioral therapy, whereas patients with severe or persistent depression can be treated with pharmacologic interventions.

Indexed as

Cognitive Behavioral TherapyPulmonary Disease, Chronic ObstructiveAnxietyDepressionHumansanxietyCBTchronic obstructive pulmonary diseasecognitive behavioral therapyCOPDdepressionmental health

Identifiers

PMID36960961
PMCPMC10037643
OpenAlexW4324045920

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read29
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.